Harvest, AL, United States of America

Gayle Stephenson-Phillips

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Nektar Therapeutics. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gayle Stephenson-Phillips. Retrieved from https://idiyas.com/inventor/gayle-stephenson-phillips

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Gayle Stephenson-Phillips

Introduction

Gayle Stephenson-Phillips is a notable inventor based in Harvest, AL (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic conjugates. With a total of 2 patents, his work has the potential to impact patient care and treatment options.

Latest Patents

His latest patents include innovative conjugates of an anti-TNF-alpha antibody. These conjugates consist of an anti-TNF antibody combined with one or more nonpeptidic water-soluble polymers, typically poly(ethylene glycol) or its derivatives. The patents also detail compositions that include these conjugates, methods for their production, and techniques for administering these compositions to patients.

Career Highlights

Gayle is currently associated with Nektar Therapeutics, where he continues to advance his research and development efforts. His work at Nektar Therapeutics has positioned him as a key player in the biotechnology sector, focusing on innovative solutions for complex medical challenges.

Collaborations

One of his notable coworkers is Mary J Bossard, who contributes to the collaborative environment at Nektar Therapeutics. Together, they work towards developing groundbreaking therapies that can improve patient outcomes.

Conclusion

Gayle Stephenson-Phillips exemplifies the spirit of innovation in biotechnology through his patents and ongoing work at Nektar Therapeutics. His contributions are paving the way for new therapeutic options that could significantly benefit patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…